| Date Filed | Type | Description |
| 07/06/2023 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 36.1% stake in RegeneRx Biopharmaceuticals, Inc. |
| 07/02/2021 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 32.2% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/16/2020 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 34.4% stake in RegeneRx Biopharmaceuticals, Inc. |
| 05/04/2020 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 16.2% stake in Fennec Pharmaceuticals Inc. |
| 05/16/2019 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 33.9% stake in RegeneRx Biopharmaceuticals, Inc. |
| 03/01/2019 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31.2% stake in RegeneRx Biopharmaceuticals, Inc. |
| 02/27/2019 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31% stake in RegeneRx Biopharmaceuticals, Inc. |
| 09/28/2018 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 28.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 03/14/2018 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 30.6% stake in RegeneRx Biopharmaceuticals, Inc. |
| 12/19/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/01/2017 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 3.9% stake in Soligenix, Inc. |
| 01/02/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 10/25/2012 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31.6% stake in RegeneRx Biopharmaceuticals, Inc. |
| 05/02/2012 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 4.3% stake in SciClone Pharmaceuticals, Inc. |
| 07/18/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/14/2011 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 32.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 07/13/2010 |
SC 13D/A
| SCICLONE PHARMACEUTICALS INC reports a 20.8% stake in SciClone Pharmaceuticals, Inc. |
| 07/09/2010 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 31.7% stake in RegeneRx Biopharmaceuticals, Inc. |
| 06/28/2010 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 30.2% stake in Soligenix, Inc. |
| 02/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/19/2009 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 38.1% stake in RegeneRx Biopharmaceuticals, Inc. |
| 10/02/2009 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 26.3% stake in Soligenix, Inc. |
| 04/21/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 03/31/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 02/20/2009 |
SC 13D
| SIGMA TAU FINANZIARIA SPA reports a 26.3% stake in DOR BioPharma, Inc. |
| 01/02/2009 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 21.3% stake in SciClone Pharmaceuticals, Inc. |
| 12/19/2008 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 37.1% stake in RegeneRx Biopharmaceuticals, Inc. |
| 12/03/2008 |
SC 13G
| SIGMA TAU FINANZIARIA SPA reports a 15.4% stake in DOR BioPharma, Inc. |